Parker-Hannifin Pre-production expens incurred in connection with research and development contracts increased by 28.9% to $58.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 28.9%, from $45.00M to $58.00M. Over 4 years (FY 2021 to FY 2025), Pre-production expens incurred in connection with research and development contracts shows relatively stable performance with a 1.8% CAGR.
An increase indicates high investment in future product innovation, while a decrease may suggest a maturing product portfolio or reduced R&D activity.
These are costs incurred in the development phase of new products or technologies prior to the commencement of commercia...
Common in aerospace and industrial manufacturing; peers often categorize these as deferred development costs or R&D assets.
other_preproduction_costs_related_to_research_and_develo_7e73ca| Q2 '21 | Q2 '22 | Q2 '23 | Q2 '24 | Q2 '25 | |
|---|---|---|---|---|---|
| Value | $54.00M | $74.00M | $73.00M | $45.00M | $58.00M |
| QoQ Change | — | +37.0% | -1.4% | -38.4% | +28.9% |
| YoY Change | — | +37.0% | -1.4% | -38.4% | +28.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.